Bariatric surgery for diabetes: Gastric banding is simple and safe

British Journal of Diabetes and Vascular Disease

Volumn 10, Issue 3, 2010, Pages 139-142

  Pinkney, Jonathan ^a  

^a ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Bariatric; Diabetes; Laparoscopic gastric banding

Indexed keywords

INCRETIN; INSULIN; PROTEIN INHIBITOR;

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BIOMIMETICS; DRUG DOSE TITRATION; FOLLOW UP; GASTRIC BANDING; HUMAN; MEDICAL DECISION MAKING; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT MONITORING; PATIENT SAFETY; PATIENT SELECTION; PROFESSIONAL KNOWLEDGE; SKILL; SODIUM GLUCOSE TRANSPORTER INHIBITOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 77957173752     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651409355107     Document Type: Article

References (21)

1. Pinkney JH, Sjöström CD, Gale eA. Should surgeons treat diabetes in severely obese people? Lancet 2001;357:1357-9
2. Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-56
3. Pinkney J, Kerrigan D. Current status of bariatric surgery in the treat-ment of type 2 diabetes. Obes Rev 2004;5:69-78
4. Chapman AE, Kiroff G, Game P et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326-51
5. The Longitudinal Assessment of Bariatric Surgery Consortium Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445-54.
6. Dixon JB, O'Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-23
7. Dolan K, Bryant R, Fielding G. Treating diabetes in the morbidly obese by laparoscopic gastric banding. Obes Surg 2003;13:439-43
8. Parikh M, Ayoung-Chee P, Romanos E et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 2007;205:631-5
9. Brancatisano A, Wahlroos S, Matthews S, Brancatisano R. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese. Surg Obes Relat Dis 2008;4:423-9
10. Keating CL, Dixon JB, Moodie ML et al. Cost-efficacy of surgically nduced weight loss for the management of type 2 diabetes: a ran-domized controlled trial. Diabetes Care 2009;32:580-4
11. Keating CL, Dixon JB, Moodie ML et al. Cost-effectiveness of surgically nduced weight loss for the management of type 2 diabetes: modeled ifetime analysis. Diabetes Care 2009;32:567-4
12. Schauer PR, Burguera B, Ikramuddin S et al. effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-84
13. O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006;16:1032-40
14. Mechanick JI, Kushner RF, Sugerman HJ et al. American Association of Clinical endocrinologists, the Obesity Society, and American Society for Metabolic and Bariatric Surgery guidelines for clinica practice for the perioperative nutritional, metabolic, and nonsurgica support of the bariatric surgery patient. Endocrine Practice 2008; 14(suppl 1):1-83
15. National Institute for Health and Clinical excellence. Obesity Guidance on the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London: NICE, 2006 www.nice.org.uk/nicemedia/ pdf/CG43NICeGuideline.pdf
16. American Diabetes Association. Summary of Revisions for the 2009 Clinical Practice Recommendations. Diabetes Care 2009;32:S3-S5
17. Rubino F, Kaplan LM, Schauer PR, Cummings DE; On behalf of the Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit Consensus Conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2009 Nov 19 (epub ahead of print).
18. Chia CW, Egan JM. Incretin-based therapies in type 2 diabetes mellitus J Clin Endocrinol Metab 2008;93:3703-16
19. Look AHEAD study research group, Pi-Sunyer X et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHeAD trial. Diabetes Care 2007; 30: 1374-83.
20. Idris I, Donnelly R. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug. Diabetes Obes Metab 2009;11:79-88.
21. Rothkopf MM, Bilof ML, Haverstick LP, Nusbaum MJ. Synergistic weight loss and diabetes resolution with exenatide administration after laparoscopic gastric banding. Surg Obes Relat Dis 2009;5:128-131